What does Fosun Capital invest in?
Fosun Capital invests most often at Series B (100% of the rounds on record), in sectors such as Consulting, Logistics and Biotechnology.

China · Investor
Last cheque observed Jul 2019. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.
QuietCompany
2 rounds on record
Mostly Series B: 100% of its rounds
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ("Fosun Pharma", stock codes: 600196.SH, 02196.HK) was established in 1994 and is a globally operating pharmaceutical and health industry group rooted in China and driven by innovation.Translated from Chinese, from their own website
Every round we can evidence, newest first2 appearances
1 round
1 round
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
Fosun Capital invests most often at Series B (100% of the rounds on record), in sectors such as Consulting, Logistics and Biotechnology.
2 investments on record, 0 of them in the last 12 months. The most recent was in Jul 2019.
Its most recent investments on record: Hinova Pharma (Series B, Jul 2019) and Tyto Care (Undisclosed round, Jan 2018).
The median round it joins is $33M.
No investments in the last 12 months; the latest was in Jul 2019.
Fosun Capital is a company based in Shanghai, China.
Fosun Capital was founded in 1994.
From 2 articles and filings naming it in a round, public registers and its own website, checked and rebuilt every night.
Find the investors who back rounds like yours, and keep every conversation on one fundraising board.
Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it